LCMV Antibodies

Santa Cruz Biotechnology offers a broad range of LCMV Antibodies for studying Lymphocytic Choriomeningitis Virus (LCMV). LCMV Antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LCMV is a significant pathogen causing viral infections in humans and rodents, leading to neurological complications and immune responses critical for understanding viral pathogenesis. Research focusing on LCMV has advanced our knowledge of viral infections and host immune responses. Understanding LCMV biology contributes significantly to vaccine development and therapeutic strategies. LCMV research provides valuable insights into mechanisms of immune evasion and host defense. Investigating LCMV-host interactions reveals important aspects of viral persistence and immune system modulation. LCMV monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of viral pathogenesis and immune responses.